Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

142.97
+12.519.59%
Pre-market: 139.90-3.0700-2.15%04:17 EDT
Volume:258.20K
Turnover:35.15M
Market Cap:75.77M
PE:- -
High:144.32
Open:124.62
Low:123.44
Close:130.46
52wk High:167.89
52wk Low:14.95
Shares:530.00K
Float Shares:530.00K
Volume Ratio:1.13
T/O Rate:48.72%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna up over 7%, on Track for Highest Close Since January 2023

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Forge Nano and Nanexa to Develop Gmp-Compatible Ald Manufacturing Equipment

Reuters
·
Sep 22

Nanexa, Forge Nano Enter Joint Development Deal on GMP-Scale ALD Equipment for PharmaShell Injectables

Reuters
·
Sep 22

Moderna Surges 12% to a New 52-Week High as Phase 3 Cancer Vaccine Data Set for October Release

Bellwether Stocks Movement
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22

Moderna Inc Stock (MRNA) Moved Up by 14.21% on Sep 21: Drivers Behind the Movement

TradingKey
·
Sep 22

Moderna Stock Jumps. Its mRNA Cancer Vaccine is Getting Ready for Its Next Big Test.

Dow Jones
·
Sep 22

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18